Cargando…
Expression of Beclin 1 and Bcl-2 in pancreatic neoplasms and its effect on pancreatic ductal adenocarcinoma prognosis
Aberrant expression of Beclin 1 and B-cell lymphoma-2 (Bcl-2) has been identified in a variety of human tumors; however, little information is available for pancreatic neoplasms. The present study analyzed the expression of Beclin 1 and Bcl-2 in pancreatic ductal adenocarcinoma (PDAC) and solid pseu...
Autores principales: | Song, Shanshan, Wang, Baosheng, Gu, Shuailin, Li, Xiaocheng, Sun, Shaolong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755265/ https://www.ncbi.nlm.nih.gov/pubmed/29344231 http://dx.doi.org/10.3892/ol.2017.7218 |
Ejemplares similares
-
Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
por: Suzuoki, M, et al.
Publicado: (2002) -
High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma
por: Li, He, et al.
Publicado: (2020) -
Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis
por: MacCurtain, Benjamin M., et al.
Publicado: (2021) -
Utilization of CDX2 Expression in Diagnosing Pancreatic Ductal Adenocarcinoma and Predicting Prognosis
por: Xiao, Wenbin, et al.
Publicado: (2014) -
Elevated glypican‐1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma
por: Lu, Haizhen, et al.
Publicado: (2017)